Biotech Stock Surges on Possible Corona Virus Vaccine

Vaxil Bio Ltd. (TSXV:VXL), a biotech stock, climbed after identifying a corona virus (COVID-19) vaccine candidate

Sean Mason | February 14, 2020 | SmallCapPower

A potential Corona Virus vaccine produced healthy gains for a Canada-listed biotech stock Friday. Here’s some small stocks making big moves on Friday, February 14, 2020 (as of 4 pm EST):

Vaxil Bio Ltd. (TSXV:VXL), a biotech stock, powered 117% higher to $0.065 on Friday after announcing that it has completed in silico analyses and believes that it has successfully identified a corona virus (COVID-19) vaccine candidate.

Win Big With Our Small Cap Picks

 

As well, shares of Invictus MD Strategies Corp. (TSXV:GENE) plunged 70% to $0.035 as the Canadian cannabis company said it has applied for creditor protection under the Companies’ Creditors Arrangement Act (Canada). Invictus MD added that it will continue its normal day-to-day operations and plans to begin a review of strategic alternatives in the immediate future.

CEMATRIX Corporation (TSXV:CVX), meanwhile, reported that it has been awarded Canadian and U.S. infrastructure contracts totaling C$5.7 million. CEMATRIX stock moved up 7% to $0.44 following the announcement.

See more Small and Micro Cap Market Movers Daily from Sean Mason. Tomorrow’s big stock market winners could be found here today!

Hi, did you know SmallCapPower accepts blog submissions? You can contact me here

Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.

To read our full disclosure, please click on the button below: